Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIFTOS MKI - Radioactive Iodine reFractory Asymptomatic Patients in Differentiated Thyroid Cancer - an Observational Study to Assess the Use of Multikinase Inhibitors

NCT02303444 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02303444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIFTOS MKI - Radioactive Iodine reFractory Asymptomatic Patients in Differentiated Thyroid Cancer - an Observational Study to Assess the Use of Multikinase Inhibitors
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
April 8, 2015
Completion date
July 24, 2020
Enrollment
667 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid neoplasms